Clik here to view.
The Last Yard: Standardization in the Clinical Lab
Dr. Harriet Feilotter, Associate Professor of Pathology and Molecular Medicine at Queen’s University in Ontario, Canada Standardization is essential in the clinical lab. But for many labs looking to...
View ArticleClik here to view.
Complete Guide to Ion Ampliseq Technology – How Does Ion Ampliseq Technology...
Next Generation Sequencing (NGS) is now producing more sequencing data, faster than anyone had ever envisioned even just 10 years ago, making it now possible to sequence a genome in days rather than...
View ArticleClik here to view.
What you Missed From Ion Torrent Technology at AGBT 2017
The AGBT annual meeting didn’t disappoint. In case we missed each other, here are a few highlights from our team: Ion ExT Kits for 600 bp sequencing on the Ion S5 System Last Thursday, Simon Cawley,...
View ArticleWhat is Cell-Free DNA (cfDNA)? – Seq It Out #19
Are you looking to start using blood samples in your translational research? Maybe you’re interested in metastatic breast cancer, or non-small cell lung. Or maybe the challenges and limitations of...
View ArticleClik here to view.
Aiming High in the Fight to End Cancer
Joydeep Goswami discusses working on the Cancer Moonshot initiative with Vice President Joe Biden’s new task force Joydeep Goswami, President of Clinical Next-Generation Sequencing and Oncology...
View ArticleClik here to view.
Did Your Favorite Blogs Make the List? – Top 10 Blogs of 2016
As we wind down 2016 and prepare for 2017, we wanted to take a step back and recap the most popular blog posts this year. We’ve highlighted below the Top 10 blogs of 2016 – Did your favorite blogs make...
View ArticleClik here to view.
ASHG 2016 Preview – What to expect in Vancouver?
How to Plan Your Time in Vancouver with Us at ASHG If you find yourself walking the streets of Vancouver the week of October 17th, chances are you’ll bump into a PhD or two. That week, the American...
View ArticleClik here to view.
Cell-free DNA NGS Assay May be Complementary to Solid Tissue Assays
Andrew Felton, PhD, Vice President of Marketing, Clinical Next Generation Sequencing The availability of a next-generation sequencing (NGS) assay using cfDNA input is enabling cancer researchers to...
View ArticleClik here to view.
Forging Partnerships to Drive Era of Precision Medicine
Andrew Felton, Vice President of Marketing, Clinical Next Generation Sequencing When I stop for a moment to evaluate where our industry stands in our collective pursuit to enable the era of genomic...
View ArticleDiscovering Cancer’s Trail: Biomarkers in Blood Samples
Research in the field of liquid biopsies has taken off at an exponential pace in the past few years. Several research studies have demonstrated the promise of peripheral monitoring as a tool for better...
View Article
